ARTICLE | Clinical News
Fibrimage: Began Phase III trial
February 7, 2000 8:00 AM UTC
Draxis Health Inc. (DRAX; TSE:DAX), Mississauga, Ontario Product: Fibrimage Business: Diagnostics/Imaging Therapeutic category: Imaging Target: Fibrin Description: Technetium-labeled recombinant poly...